β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.

Gowri, Meiyazhagan

β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway. [electronic resource] - Biochimica et biophysica acta Apr 2016 - 636-47 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0006-3002

10.1016/j.bbagen.2015.12.020 doi


14-alpha Demethylase Inhibitors--pharmacology
Antifungal Agents--chemistry
Candida albicans--growth & development
Candidiasis--drug therapy
Cyclic AMP--metabolism
Dental Pulp Cavity--metabolism
Humans
Models, Biological
Second Messenger Systems
Sterol 14-Demethylase--metabolism
beta-Lactams--chemistry